ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 83 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 205.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,417,000 | -42.7% | 367,200 | 0.0% | 0.13% | -43.5% |
| Q4 2014 | $2,471,000 | +22.6% | 367,200 | 0.0% | 0.24% | +13.9% |
| Q3 2014 | $2,016,000 | -46.4% | 367,200 | 0.0% | 0.21% | -35.6% |
| Q2 2014 | $3,764,000 | -14.6% | 367,200 | 0.0% | 0.32% | -10.3% |
| Q1 2014 | $4,410,000 | +6.2% | 367,200 | 0.0% | 0.36% | +5.6% |
| Q4 2013 | $4,153,000 | – | 367,200 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |